SCHEMBL20127233

SCHEMBL20127233

c1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3ccc(-c4ccc(-c5ccc(-n6c7ccccc7c7cc8c(cc76)c6ccccc6n8-c6cc(-c7ccccc7)cc(-c7ccccc7)c6)cc5)cc4)cc3)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ATM Q13315 1/20 0.55
HDAC4 P56524 1/20 0.44
KMT2A Q03164 4/20 0.39
IL1R1 P14778 1/20 0.39
MEN1 O00255 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
AKR1C4 P17516 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
AKR1C1 Q04828 1/20 0.37
PTPN1 P18031 2/20 0.36
TSPO P30536 1/20 0.35
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127234 1.00 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17019437 1.00 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17019441 1.00 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17019445 0.97 L3MBTL1 (0.60) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL18715849 0.95 L3MBTL1 (0.55) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL18253716 0.95 L3MBTL1 (0.53) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17228227 0.95 L3MBTL1 (0.62) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL15988942 0.95 L3MBTL1 (0.62) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL16452323 0.95 L3MBTL1 (0.52) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL13039490 0.95 L3MBTL1 (0.61) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD. (CN) 2018-05-10 US disclosed
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT GUANGZHOU CHINARAY OPTOELECTRONICS MATERIALS LTD. (CN) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130955-A1 ORGANIC COMPOUND, MIXTURE COMPRISING SAME, COMPOSITE, AND ORGANIC ELECTRONIC COMPONENT OCIAD1, OCIAD2, SRD5A1 L3MBTL1 1639/4885KDM4E 2236/4885ATM 1986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.